Expression and function of multidrug resistance transporters at the blood–brain barriers

Bibliography

• GOLDSTEIN GW, BETZ AL: The blood- brain barrier. Sci. Am. (1986) 255(3):74–83.
   PubMed Web of Science ®Google Scholar
• STEWART PA, WILEY MJ: Developing nervous tissue induces formation of blood- brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. (1981) 84(1):183–192.
   PubMed Web of Science ®Google Scholar
• BALABANOV R, DORE-DUFFY P: Role of the CNS microvascular pericyte in the blood-brain barrier. J. Neurosci. Res. (1998) 53(6):637–644.
   PubMed Web of Science ®Google Scholar
• SPECTOR R, JOHANSON CE: The mammalian choroid plexus. Sci. Am. (1989) 261(5):68–74.
   PubMed Web of Science ®Google Scholar
• PARDRIDGE WM: Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug Del. Rev. (1997) 17 (7):713–731.
   Google Scholar
• PARDRIDGE WM: Drug delivery to the brain. J. Cereb. Blood Flow Metab. (1997) 17(7):713–731.
   PubMed Web of Science ®Google Scholar
• TAMAI I, TSUJI A: Transporter-mediated permeation of drugs across the blood-brain barrier. J. Pharm. Sci. (2000) 89(11):1371–1388.
   PubMed Web of Science ®Google Scholar
• SCHERRMANN JM: Drug delivery to brain via the blood-brain barrier. Vascul. Pharmacol. (2002) 38(6):349–354.
   PubMed Web of Science ®Google Scholar
• LEVIN VA: Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. (1980) 23(6):682–684.
   PubMed Web of Science ®Google Scholar
• BIEDLER JL, RIEHM H: Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. (1970) 30(4):1174–1184.
   PubMed Web of Science ®Google Scholar
• KESSEL D, BOSMANN HB: On the characteristics of actinomycin D resistance in L5178Y cells. Cancer Res. (1970) 30(11):2695–2701.
   PubMed Web of Science ®Google Scholar
• JULIANO RL, LING V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta (1976) 455(1):152–162.
   PubMed Web of Science ®Google Scholar
• CORDON-CARDO C, O’BRIEN JP, CASALS D et al.: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA (1989) 86(2):695–698.
   PubMed Web of Science ®Google Scholar
• THIEBAULT F, TSURUO T, HAMADA H et al.: Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. (1989) 37(2):159–164.
   PubMed Web of Science ®Google Scholar
• LEE G, DALLAS S, HONG M, BENDAYAN R: Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol. Rev. (2001) 53(4):569–596.
   PubMed Web of Science ®Google Scholar
• BORST P, EVERS R, KOOL M, WIJNHOLDS J: The multidrug resistance protein family. Biochim. Biophys. Acta (1999) 1461(2):347–357.
   PubMed Web of Science ®Google Scholar
• DEAN M, RZHETSKY A, ALLIKMETS R: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. (2001) 11(7):1156–1166.
   PubMed Web of Science ®Google Scholar
• KARTNER N, SHALES M, RIORDAN JR, LING V: Daunorubicinresistant Chinese hamster ovary cells expressing multidrug resistance and a cellsurface P-glycoprotein. Cancer Res. (1983) 43(9):4413–4419.
   PubMedGoogle Scholar
• SEELIG A: A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. (1998) 251(1–2):252–261.
   PubMedGoogle Scholar
• AMBUDKAR SV, DEY S, HRYCYNA CA et al. : Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. (1999) 39:361–398.
   PubMed Web of Science ®Google Scholar
• MARTIN C, BERRIDGE G, HIGGINS CF et al.: Communication between multiple drug binding sites on P-glycoprotein. Mol. Pharmacol. (2000) 58(3):624–632.
   PubMed Web of Science ®Google Scholar
• DEVAULT A, GROS P: Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell Biol. (1990) 10(4):1652–1663.
   PubMed Web of Science ®Google Scholar
• PARDRIDGE WM, GOLDEN PL, KANG YS, BICKEL U: Brain microvascular and astrocyte localization of P-glycoprotein. J. Neurochem. (1997) 68(3):1278–1285.
   PubMed Web of Science ®Google Scholar
• REGINA A, KOMAN A, PICIOTTI M et al.: Mrp1 multidrug resistance-associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J. Neurochem. (1998) 71(2):705–715.
   PubMed Web of Science ®Google Scholar
• HEGMANN EJ, BAUER HC, KERBEL RS: Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. (1992) 52(24):6969–6975.
   PubMed Web of Science ®Google Scholar
• TSUJI A, TERASAKI T, TAKABATAKE Y et al.: P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. (1992) 51(18):1427–1437.
   PubMed Web of Science ®Google Scholar
• SUGAWARA I, HAMADA H, TSURUO T, MORI S: Specialized localization of P-glycoprotein recognized by MRK 16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. (1990) 81(8):727–730.
   PubMedGoogle Scholar
• VAN DER VALK P, VAN KALKEN CK, KETELAARS H et al.: Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Ann. Oncol. (1990) 1(1):56–64.
   PubMed Web of Science ®Google Scholar
• BEAULIEU E, DEMEULE M, GHITESCU L, BELIVEAU R: P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem. J. (1997) 326(Pt 2):539–544.
   PubMed Web of Science ®Google Scholar
• DECLEVES X, FAJAC A, LEHMANN-CHE J et al.: Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines. Int. J. Cancer (2002) 98(2):173–180.
   PubMed Web of Science ®Google Scholar
• RONALDSON PT, BENDAYAN M, GINGRAS D, PIQUETTE-MILLER M, BENDAYAN R: Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J. Neurochem. (2004) 89(3):788–800.
   PubMed Web of Science ®Google Scholar
• MERCIER C, MASSEGUIN C, ROUX F, GABRION J, SCHERRMANN JM: Expression of P-glycoprotein (ABCB1) and Mrp1 (ABCC1) in adult rat brain: focus on astrocytes. Brain Res. (2004) 1021(1):32–40.
   PubMed Web of Science ®Google Scholar
• TISHLER DM, WEINBERG KI, HINTON DR et al.: MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia (1995) 36(1):1–6.
   PubMed Web of Science ®Google Scholar
• DOMBROWSKI SM, DESAI SY, MARRONI M et al.: Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy. Epilepsia (2001) 42(12):1501–1506.
   PubMed Web of Science ®Google Scholar
• LU Y, YAN Y, WANG XF: Antiepileptic drug-induced multidrug resistance P-glycoprotein overexpression in astrocytes cultured from rat brains. Chin. Med. J. (2004) 117(11):1682–1686.
   PubMed Web of Science ®Google Scholar
• BOMBARDI C, GRANDIS A, CHIOCCHETTI R et al.: Membranetransport systems in the fenestrated capillaries of the area postrema in rat and calf. Anat. Rec. A Discov. Mol. Cell Evol. Biol. (2004) 279(1):664–670.
   PubMedGoogle Scholar
• RAO VV, DAHLHEIMER JL, BARDGETT ME et al.: Choroid plexus epithelial expression of MDR1 P-glycoprotein and multidrug resistanceassociated protein contribute to the blood- cerebrospinal fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA (1999) 96(7):3900–3905.
   PubMed Web of Science ®Google Scholar
• SCHINKEL AH, SMIT JJ, VAN TELLINGEN O et al.: Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell (1994) 77(4):491–502.
   PubMed Web of Science ®Google Scholar
• BARRAND MA, ROBERTSON KJ, VON WEIKERSTHAL SF: Comparisons of P-glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett. (1995) 374(2):179–183.
   PubMed Web of Science ®Google Scholar
• SCHINKEL AH: P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. (1999) 36(2–3):179–194.
   PubMed Web of Science ®Google Scholar
• MAYER U, WAGENAAR E, BEIJNEN JH et al.: Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br. J. Pharmacol. (1996) 119(5):1038–1044.
   PubMed Web of Science ®Google Scholar
• CISTERNINO S, ROUSSELLE C, DAGENAIS C, SCHERRMANN JM: Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice. Pharm. Res. (2001) 18(2):183–190.
   PubMed Web of Science ®Google Scholar
• ELSINGA PH, HENDRIKSE NH, BART J, VAALBURG W, VAN WAARDE A: PET studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr. Pharm. Des. (2004) 10(13):1493–1503.
   PubMed Web of Science ®Google Scholar
• CISTERNINO S, ROUSSELLE C, DEBRAY M, SCHERRMANN JM: In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood- brain barrier. Pharm. Res. (2004) 21(8):1382–1389.
   PubMed Web of Science ®Google Scholar
• CISTERNINO S, ROUSSELLE C, DEBRAY M, SCHERRMANN JM: In vivo saturation of the transport of vinblastine and colchicine by P-glycoprotein at the rat blood-brain barrier. Pharm. Res. (2003) 20(10):1607–1611.
   PubMed Web of Science ®Google Scholar
• CISTERNINO S, BOURASSET F, ARCHIMBAUD Y et al.: Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats. Br. J. Pharmacol. (2003) 138(7):1367–1375.
   PubMed Web of Science ®Google Scholar
• GARRIGUES A, LOISEAU N, DELAFORGE M et al.: Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. Mol. Pharmacol. (2002) 62(6):1288–1298.
   PubMed Web of Science ®Google Scholar
• SHAPIRO AB, FOX K, LAM P, LING V: Stimulation of P-glycoprotein-mediated drug transport by prazosin and progesterone. Evidence for a third drugbinding site. Eur. J. Biochem. (1999) 259(3):841–850.
   PubMedGoogle Scholar
• SADEQUE AJ, WANDEL C, HE H, SHAH S, WOOD AJ: Increased drug delivery to the brain by P-glycoprotein inhibition. Clin. Pharmacol. Ther. (2000) 68(3):231–237.
   PubMed Web of Science ®Google Scholar
• SCHINKEL AH, WAGENAAR E, MOL CA, VAN DEEMTER L: P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest (1996) 97(11):2517–2524.
   PubMed Web of Science ®Google Scholar
• THOMPSON SJ, KOSZDIN K, BERNARDS CM: Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology (2000) 92(5):1392–1399.
   PubMed Web of Science ®Google Scholar
• DAGENAIS C, ROUSSELLE C, POLLACK GM, SCHERRMANN JM: Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice. J. Cereb. Blood Flow Metab. (2000) 20(2):381–386.
   PubMed Web of Science ®Google Scholar
• MEALEY KL, BENTJEN SA, GAY JM, CANTOR GH: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics (2001) 11(8):727–733.
   PubMedGoogle Scholar
• MARZOLINI C, PAUS E, BUCLIN T, KIM RB: Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. (2004) 75(1):13–33.
   PubMed Web of Science ®Google Scholar
• ROBERTS RL, JOYCE PR, MULDER RT, BEGG EJ, KENNEDY MA: A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. Pharmacogenomics. J. (2002) 2(3):191–196.
   PubMedGoogle Scholar
• DE LUCA V, MUNDO E, TRAKALO J, WONG GW, KENNEDY JL: Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics. J. (2003) 3(5):297–299.
   PubMed Web of Science ®Google Scholar
• YI SY, HONG KS, LIM HS et al.: A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clin. Pharmacol. Ther. (2004) 76(5):418–427.
   PubMed Web of Science ®Google Scholar
• DROZDZIK M, BIALECKA M, MYSLIWIEC K et al.: Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson’s disease. Pharmacogenetics (2003) 13(5):259–263.
   PubMedGoogle Scholar
• SIDDIQUI A, KERB R, WEALE ME et al.: Association of multidrug resistance in epilepsy with a polymorphism in the drugtransporter gene ABCB1. N. Engl. J. Med. (2003) 348(15):1442–1448.
   PubMed Web of Science ®Google Scholar
• HARTZ AM, BAUER B, FRICKER G, MILLER DS: Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1. Mol. Pharmacol. (2004) 66(3):387–394.
   PubMed Web of Science ®Google Scholar
• BAUER B, HARTZ AM, FRICKER G, MILLER DS: Pregnane X receptor upregulation of P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol. (2004) 66(3):413–419.
   PubMed Web of Science ®Google Scholar
• COLE SP, BHARDWAJ G, GERLACH JH et al.: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (1992) 258(5088):1650–1654.
   PubMed Web of Science ®Google Scholar
• BORST P, EVERS R, KOOL M, WIJNHOLDS J: A family of drug transporters: the multidrug resistanceassociated proteins. J. Natl. Cancer Inst. (2000) 92(16):1295–1302.
   PubMed Web of Science ®Google Scholar
• KRUH GD, BELINSKY MG: The MRP family of drug efflux pumps. Oncogene (2003) 22(47):7537–7552.
   PubMed Web of Science ®Google Scholar
• HAIMEUR A, CONSEIL G, DEELEY RG, COLE SP: The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr. Drug Metab. (2004) 5(1):21–53.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, HAN H, ELMQUIST WF, MILLER DW: Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res. (2000) 876(1–2):148–153.
   Google Scholar
• ZHANG Y, SCHUETZ JD, ELMQUIST WF, MILLER DW: Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells. J. Pharmacol. Exp. Ther. (2004) 311(2):449–455.
   PubMed Web of Science ®Google Scholar
• FLENS MJ, SCHEFFER GL, VAN DV et al.: Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies. Int. J. Cancer (1997) 73(2):249–257.
   PubMed Web of Science ®Google Scholar
• SEETHARAMAN S, MASKELL L, SCHEPER RJ, BARRAND MA: Changes in multidrug transporter protein expression in endothelial cells cultured from isolated human brain microvessels. Int. J. Clin. Pharmacol. Ther. (1998) 36(2):81–83.
   PubMed Web of Science ®Google Scholar
• GUTMANN H, TOROK M, FRICKER G et al.: Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro. Drug Metab. Dispos. (1999) 27(8):937–941.
   Google Scholar
• CISTERNINO S, ROUSSELLE C, LORICO A, RAPPA G, SCHERRMANN JM: Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells. Pharm. Res. (2003) 20(6):904–909.
   PubMed Web of Science ®Google Scholar
• SUGIYAMA D, KUSUHARA H, LEE YJ, SUGIYAMA Y: Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier. Pharm. Res. (2003) 20(9):1394–1400.
   PubMed Web of Science ®Google Scholar
• MILLER DS, NOBMANN SN, GUTMANN H et al.: Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. (2000) 58(6):1357–1367.
   PubMed Web of Science ®Google Scholar
• POTSCHKA H, FEDROWITZ M, LOSCHER W: Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. J. Pharmacol. Exp. Ther. (2003) 306(1):124–131.
   PubMed Web of Science ®Google Scholar
• LEGGAS M, ADACHI M, SCHEFFER GL et al. : Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell Biol. (2004) 24(17):7612–7621.
   PubMed Web of Science ®Google Scholar
• NIES AT, JEDLITSCHKY G, KONIG J et al.: Expression and immunolocalization of the multidrug resistance proteins, MRP1- MRP6 (ABCC1 - ABCC6), in human brain. Neuroscience (2004) 129(2):349–360.
   PubMed Web of Science ®Google Scholar
• DECLEVES X, REGINA A, LAPLANCHE JL et al.: Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J. Neurosci. Res. (2000) 60(5):594–601.
   PubMed Web of Science ®Google Scholar
• DALLAS S, SCHLICHTER L, BENDAYAN R: Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl) adenine by microglia. J. Pharmacol. Exp. Ther. (2004) 309(3):1221–1229.
   PubMed Web of Science ®Google Scholar
• HIRRLINGER J, KONIG J, DRINGEN R: Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. (2002) 82(3):716–719.
   PubMed Web of Science ®Google Scholar
• BEREZOWSKI V, LANDRY C, DEHOUCK MP, CECCHELLI R, FENART L: Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistanceassociated proteins in an in vitro model of the blood-brain barrier. Brain Res. (2004) 1018(1):1–9.
   PubMed Web of Science ®Google Scholar
• STRAZIELLE N, GHERSI-EGEA JF: Demonstration of a coupled metabolismefflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J. Neurosci. (1999) 19(15):6275–6289.
   PubMed Web of Science ®Google Scholar
• LEE YJ, KUSUHARA H, SUGIYAMA Y: Do multidrug resistance-associated protein-1 and -2 play any role in the elimination of estradiol-17 beta-glucuronide and 2,4- dinitrophenyl-S-glutathione across the blood-cerebrospinal fluid barrier? J. Pharm. Sci. (2004) 93(1):99–107.
   PubMed Web of Science ®Google Scholar
• DOYLE LA, YANG W, ABRUZZO LV et al. : A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA (1998) 95(26):15665–15670.
   PubMed Web of Science ®Google Scholar
• LITMAN T, BRANGI M, HUDSON E et al.: The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci. (2000) 113:2011–2021.
   PubMed Web of Science ®Google Scholar
• GUPTA A, ZHANG Y, UNADKAT JD, MAO Q: HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ ABCG2). J. Pharmacol. Exp. Ther. (2004) 310(1):334–341.
   PubMed Web of Science ®Google Scholar
• COORAY HC, BLACKMORE CG, MASKELL L, BARRAND MA: Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport (2002) 13(16):2059–2063.
   PubMed Web of Science ®Google Scholar
• EISENBLATTER T, GALLA HJ: A new multidrug resistance protein at the blood- brain barrier. Biochem. Biophys. Res. Commun. (2002) 293(4):1273–1278.
   PubMed Web of Science ®Google Scholar
• EISENBLATTER T, HUWEL S, GALLA HJ: Characterisation of the brain multidrug resistance protein (BMDP/ ABCG2/BCRP) expressed at the blood- brain barrier. Brain Res. (2003) 971(2):221–231.
   PubMed Web of Science ®Google Scholar
• ZHANG W, MOJSILOVIC-PETROVIC J, ANDRADE MF et al.: The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. (2003) 17(14):2085–2087.
   PubMed Web of Science ®Google Scholar
• HORI S, OHTSUKI S, TACHIKAWA M et al.: Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s). J. Neurochem. (2004) 90(3):526–536.
   PubMed Web of Science ®Google Scholar
• CISTERNINO S, MERCIER C, BOURASSET F, ROUX F, SCHERRMANN JM: Expression, upregulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. (2004) 64(9):3296–3301.
   PubMed Web of Science ®Google Scholar
• LEE YJ, KUSUHARA H, JONKER JW, SCHINKEL AH, SUGIYAMA Y: Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein. J. Pharmacol. Exp. Ther. (2005) 312(1):44–52.
   PubMed Web of Science ®Google Scholar
• JONKER JW, BUITELAAR M, WAGENAAR E et al.: The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA (2002) 99(24):15649–15654.
   PubMed Web of Science ®Google Scholar
• HONJO Y, HRYCYNA CA, YAN QW et al.: Acquired mutations in the MXR/ BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. (2001) 61(18):6635–6639.
   PubMed Web of Science ®Google Scholar
• IMAI Y, NAKANE M, KAGE K et al.: C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. (2002) 1(8):611–616.
   PubMed Web of Science ®Google Scholar
• BEGLEY DJ: ABC transporters and the blood-brain barrier. Curr. Pharm. Des (2004) 10(12):1295–1312.
   PubMed Web of Science ®Google Scholar